Connection
Eric Wu to Lymphoma, Large B-Cell, Diffuse
This is a "connection" page, showing publications Eric Wu has written about Lymphoma, Large B-Cell, Diffuse.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.799 |
|
|
|
-
Yang H, Hao Y, Chai X, Qi CZ, Wu EQ. Estimation of total costs in patients with relapsed or refractory diffuse large B-cell lymphoma receiving tisagenlecleucel from a US hospital's perspective. J Med Econ. 2020 Sep; 23(9):1016-1024.
Score: 0.632
-
Wakase S, Teshima T, Zhang J, Ma Q, Fujita T, Yang H, Chai X, Qi CZ, Liu Q, Wu EQ, Igarashi A. Cost Effectiveness Analysis of Tisagenlecleucel for the Treatment of Adult Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma in Japan. Transplant Cell Ther. 2021 06; 27(6):506.e1-506.e10.
Score: 0.167